Vanguard Group Portfolio holdings
AUM $6.18T
1-Year Return
25.19%
The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.
This Quarter Return
+9.24%
1 Year Return
+25.19%
3 Year Return
+103.99%
5 Year Return
+190.29%
10 Year Return
+458.75%
AUM
$4.22T
AUM Growth
+$290B
(+7.4%)
Cap. Flow
+$3.96B
Cap. Flow
% of AUM
0.09%
Top 10 Holdings %
Top 10 Hldgs %
22.86%
Holding
4,650
New
94
Increased
2,049
Reduced
1,931
Closed
102
Top Buys
| 1 |
CoStar Group
CSGP
|
+$1.76B |
| 2 |
Palo Alto Networks
PANW
|
+$1.56B |
| 3 |
Microsoft
MSFT
|
+$1.26B |
| 4 |
Walmart
WMT
|
+$960M |
| 5 |
Xylem
XYL
|
+$754M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$1.8B |
| 2 |
Visa
V
|
+$1.26B |
| 3 |
Mastercard
MA
|
+$1.25B |
| 4 |
Apple
AAPL
|
+$1.2B |
| 5 |
Cadence Design Systems
CDNS
|
+$965M |
Sector Composition
| 1 | Technology | 26.68% |
| 2 | Healthcare | 12.98% |
| 3 | Financials | 12.3% |
| 4 | Consumer Discretionary | 10.42% |
| 5 | Industrials | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1926
Spotify
SPOT
$146B
| $87.2M | ﹤0.01% |
543,363
+5,643
| +1% | +$906K |
|
1927
Protagonist Therapeutics
PTGX
$3.68B
| $86.9M | ﹤0.01% |
3,147,755
-93,538
| -3% | -$2.58M |
|
|
HTLF
1928
DELISTED
Heartland Financial USA, Inc.
HTLF
| $86.8M | ﹤0.01% |
3,113,561
+28,413
| +0.9% | +$792K |
|
1929
Regenxbio
RGNX
$456M
| $86.8M | ﹤0.01% |
4,340,042
+23,021
| +0.5% | +$460K |
|
1930
Deluxe
DLX
$876M
| $86.5M | ﹤0.01% |
4,951,225
-50,803
| -1% | -$888K |
|
1931
Innoviva
INVA
$1.22B
| $86.4M | ﹤0.01% |
6,788,754
-408,817
| -6% | -$5.2M |
|
1932
Heartland Express
HTLD
$650M
| $86.2M | ﹤0.01% |
5,252,828
-96,584
| -2% | -$1.58M |
|
1933
Kymera Therapeutics
KYMR
$3.44B
| $86.1M | ﹤0.01% |
3,743,088
+9,163
| +0.2% | +$211K |
|
1934
CRISPR Therapeutics
CRSP
$5.37B
| $86M | ﹤0.01% |
1,531,090
+46,521
| +3% | +$2.61M |
|
1935
LivaNova
LIVN
$2.98B
| $85.9M | ﹤0.01% |
1,670,144
+76,433
| +5% | +$3.93M |
|
1936
Geron
GERN
$810M
| $85.7M | ﹤0.01% |
26,683,233
+4,141,265
| +18% | +$13.3M |
|
1937
Coeur Mining
CDE
$10.3B
| $85.6M | ﹤0.01% |
30,148,035
+2,621,110
| +10% | +$7.44M |
|
1938
Opko Health
OPK
$1.1B
| $85.3M | ﹤0.01% |
39,310,784
-2,244,148
| -5% | -$4.87M |
|
1939
Adient
ADNT
$1.99B
| $84.9M | ﹤0.01% |
2,214,521
+8,067
| +0.4% | +$309K |
|
1940
AvePoint
AVPT
$3.27B
| $84.4M | ﹤0.01% |
14,657,136
+1,351,528
| +10% | +$7.78M |
|
1941
Janus International
JBI
$1.41B
| $84.4M | ﹤0.01% |
7,914,587
+1,380,106
| +21% | +$14.7M |
|
|
SLCA
1942
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $84.3M | ﹤0.01% |
6,949,789
+159,514
| +2% | +$1.93M |
|
1943
Recursion Pharmaceuticals
RXRX
$2.06B
| $84.1M | ﹤0.01% |
11,259,832
+326,248
| +3% | +$2.44M |
|
|
EVRI
1944
DELISTED
Everi Holdings
EVRI
| $83.8M | ﹤0.01% |
5,795,478
+94,231
| +2% | +$1.36M |
|
1945
Donnelley Financial Solutions
DFIN
$1.47B
| $83.7M | ﹤0.01% |
1,837,624
+106,178
| +6% | +$4.83M |
|
1946
Leonardo DRS
DRS
$11.1B
| $83.6M | ﹤0.01% |
4,822,794
+947,953
| +24% | +$16.4M |
|
|
BRSP
1947
BrightSpire Capital
BRSP
$740M
| $83.5M | ﹤0.01% |
12,409,139
+434,991
| +4% | +$2.93M |
|
1948
Viking Therapeutics
VKTX
$2.6B
| $82.9M | ﹤0.01% |
5,112,357
+1,053,718
| +26% | +$17.1M |
|
1949
Lightspeed Commerce
LSPD
$1.71B
| $82.3M | ﹤0.01% |
4,865,611
+81,241
| +2% | +$1.37M |
|
1950
FuelCell Energy
FCEL
$247M
| $82.3M | ﹤0.01% |
1,270,111
-19,753
| -2% | -$1.28M |
|